Cannabis use and cannabis use disorder

JP Connor, D Stjepanović, B Le Foll, E Hoch… - Nature Reviews …, 2021 - nature.com
Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects~
10% of the 193 million cannabis users worldwide. The individual and public health burdens …

Public health implications of legalising the production and sale of cannabis for medicinal and recreational use

W Hall, D Stjepanović, J Caulkins, M Lynskey, J Leung… - The Lancet, 2019 - thelancet.com
We assess the current and describe possible future public health impacts of the legalisation
of cannabis production, sale, and use in the Americas. First, we describe global patterns of …

Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis

JD Kosiba, SA Maisto, JW Ditre - Social science & medicine, 2019 - Elsevier
Rationale Certifications for medical cannabis are generally restricted to a small number of
specific medical conditions, yet patients frequently report symptoms of pain, anxiety, and …

Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population

AC Bradford, WD Bradford, A Abraham… - JAMA internal …, 2018 - jamanetwork.com
Importance Opioid-related mortality increased by 15.6% from 2014 to 2015 and increased
almost 320% between 2000 and 2015. Recent research finds that the use of all pain …

Medical use of cannabis and cannabinoids containing products–Regulations in Europe and North America

R Abuhasira, L Shbiro, Y Landschaft - European journal of internal …, 2018 - Elsevier
Abstract In 1937, the United States of America criminalized the use of cannabis and as a
result its use decreased rapidly. In recent decades, there is a growing interest in the wide …

A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers

LM Philpot, JO Ebbert, RT Hurt - BMC Family practice, 2019 - Springer
Background Healthcare providers play a critical role in facilitating patient access to medical
cannabis. However, previous surveys suggest only a minority of providers believe that …

Legal and regulatory issues governing cannabis and cannabis-derived products in the United States

A Mead - Frontiers in plant science, 2019 - frontiersin.org
This chapter provides an in-depth discussion of the legal and regulatory frameworks
surrounding cannabis in the United States, including federal law—as dictated by the …

Mapping cannabis potency in medical and recreational programs in the United States

MC Cash, K Cunnane, C Fan, EA Romero-Sandoval - PloS one, 2020 - journals.plos.org
Cannabis related online searches are associated with positive attitudes toward medical
cannabis, particularly when information is obtained from dispensaries. Since pain is the …

Joint perceptions of the risk and availability of cannabis in the United States, 2002-2018

NS Levy, PM Mauro, CM Mauro, LE Segura… - Drug and alcohol …, 2021 - Elsevier
Background Prior work suggests that perceived risk and perceived availability of cannabis
independently affect cannabis use. However, perceived risk likely modifies the effect of …

Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability

ZD Cooper, G Bedi, D Ramesh, R Balter… - …, 2018 - nature.com
Cannabinoids combined with opioids produce synergistic antinociceptive effects,
decreasing the lowest effective antinociceptive opioid dose (ie, opioid-sparing effects) in …